RecruitingPhase 3NCT05980949Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyChandler, AZ · +145 more sites
RecruitingPhase 3NCT06585787A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb companyChandler, AZ · Gilbert, AZ · Phoenix, AZ · +99 more sites
RecruitingPhase 3NCT06947941A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)Sponsor: Bristol-Myers SquibbGilbert, AZ · +5 more sites